| Net loss | -2.72M |
| Share-based compensation | 139.53K |
| Depreciation and amortization | 207.12K |
| Amortization of deferred financing costs | 198.83K |
| Amortization of debt discount | 524.82K |
| Accretion of preferred stock | 269.05K |
| Change in fair value of put warrants | 2.76M |
| Deferred income taxes | -137.86K |
| Accounts receivable - contracts, net | -824.39K |
| Costs and earnings in excess of billings on uncompleted contracts | 3.03M |
| Restricted cash | 0 |
| Prepaid expenses | 677.36K |
| Other current assets | -561.29K |
| Other non-current assets | 184.74K |
| Accounts payable and accrued expenses | -3.16M |
| Accrued salaries and related liabilities | -175.5K |
| Other current liabilities | -144.17K |
| Other non-current liabilities | -35.3K |
| Net cash provided by (used in) operating activities | 240.81K |
| Purchase of property and equipment | -5.23K |
| Net cash used in investing activities | -5.23K |
| Bank overdraft | 74.08K |
| Proceeds from notes payable | 0 |
| Payments on mandatorily redeemable preferred stock | -100K |
| Debt issuance costs | 0 |
| Proceeds from line of credit | 22.93M |
| Payments on line of credit | -23.24M |
| Net cash (used in) provided by financing activities | -330.33K |
| Net decrease in cash and cash equivalents | -94.75K |
| Cash and equivalents, beginning of period | 94.75K |
| Cash and cash equivalents, end of period | 0 |
| Cash paid for income taxes | 340.36K |
| Cash paid for interest | 489.84K |
| Issuance of 367,103 shares and 3,428,571 shares of common stock in lieu of cash payment on financing fee incurred on amendment and/or issuance of promissory note as of June 30, 2011 and 2010, respectively | 55.06K |
| Debt issuance costs incurred but not paid | 0 |